Custom-Made Molecules
Ruth Williams | Aug 21, 2017
A new prototype machine can make the biological molecules of one’s choice from digital DNA sequences.
FDA Approves First Treatment for Spinal Muscular Atrophy
Ben Andrew Henry | Dec 28, 2016
The oligonucleotide therapeutic will soon be available in the U.S.
Oligonucleotide Therapeutics Near Approval
Catherine Offord | Dec 1, 2016
Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.
Speaking of Neuroscience
Jef Akst, Mary Beth Aberlin | Nov 18, 2016
A selection of notable quotes from the annual Society for Neuroscience meeting